Evidence map›Paper›PMID 27461081›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2017

Reciprocal Catecholamine Changes during Opiate Exposure and Withdrawal.

Megan E Fox, Nathan T Rodeberg, R Mark Wightman

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. The Mechanisms Involved in Morphine Addiction: An Overview.International journal of molecular sciences · 2019
    Review
  15. Electrochemistry at the Synapse.Annual review of analytical chemistry (Palo Alto, Calif.) · 2019
    Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Megan E FoxDepartment of Chemistry and Neuroscience Center, University of North Carolina, Chapel Hill, NC, USA.
Nathan T RodebergDepartment of Chemistry and Neuroscience Center, University of North Carolina, Chapel Hill, NC, USA.
R Mark WightmanDepartment of Chemistry and Neuroscience Center, University of North Carolina, Chapel Hill, NC, USA.
University of North Carolina at Chapel Hill · US

Funding

DYNAMICS OF IN VIVO DOPAMINE RELEASER01DA010900 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WIGHTMAN, ROBERT MARK · 1997 to 2017
$5.1M
NIDA NIH HHS R01 DA010900
6 · The paper itself

Abstract

Dysregulated catecholamine signaling has long been implicated in drug abuse. Although much is known about adaptations following chronic drug administration, little work has investigated how a single drug exposure paired with withdrawal influences catecholamine signaling in vivo. We used fast-scan cyclic voltammetry in freely moving rats to measure real-time catecholamine overflow during acute morphine exposure and naloxone-precipitated withdrawal in two regions associated with the addiction cycle: the dopamine-dense nucleus accumbens (NAc) and norepinephrine-rich ventral bed nucleus of the stria terminalis (vBNST). We compared dopamine transients in the NAc with norepinephrine concentration changes in the vBNST, and correlated release with specific withdrawal-related behaviors. Morphine increased dopamine transients in the NAc, but did not elicit norepinephrine responses in the vBNST. Conversely, dopamine output was decreased during withdrawal, while norepinephrine was released in the vBNST during specific withdrawal symptoms. Both norepinephrine and withdrawal symptoms could be elicited in the absence of morphine by administering naloxone with an α

Indexed as

Adrenergic alpha-2 Receptor AntagonistsAnimalsDisease Models, AnimalDopamineMaleMorphineNaloxoneNarcotic AntagonistsNarcoticsNorepinephrineNucleus AccumbensRatsRats, Sprague-DawleySeptal NucleiSubstance Withdrawal SyndromeAdrenergic alpha-2 Receptor AntagonistsDopamineMorphineNaloxoneNarcotic AntagonistsNarcoticsNorepinephrine

Identifiers

PMID27461081
PMCPMC5240169
OpenAlexW2478062705

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.